Photo of Bexis

As lawyers, we have to get client approval before we can discuss their litigation substantively.  Here are a couple just-in decisions where we’re doing that, but that are important enough our readers would want to know about them right away.  In re Incretin-Based Therapies Products Liability Litigation, slip op. (S.D. Cal. Nov. 9, 2015) (win on Levine “clear evidence” prescription drug preemption); In re Testosterone Replacement Therapy Products Liability Litigation, slip op. (N.D. Ill. Nov. 9, 2015) (win on generic drug preemption involving reference listed drugs).  Assuming we get approval to discuss these decisions later, we will.